TECHNICOLOR GAMES SOLIDIFIES ITS FOOTPRINT IN THE VIDEO GAMES MARKET WITH NEW LEADERSHIP AND BUSINESS LINES
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Turning Point Therapeutics, Inc. , UB Bancorp , Sprague Resources LP , Gesher I Acquisition Corp.
Latest OpenText Business Network Cloud Innovations Drive Seamless Connectivity Across Digital Ecosystems
Final Data From Phase 3 ASCENT Study Demonstrates Trodelvy Extends Overall Survival Over Chemotherapy in Second-Line Metastatic TNBC
FDA APPROVES RIABNI , A BIOSIMILAR TO RITUXAN® , FOR ADULTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS
Latin Metals and AngloGold Enter into Definitive Option Agreement Regarding Gold Exploration Projects, Salta Province, Argentina
Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine and Therapy Research and Unlocking Deeper Analytical Insights
Brunswick Exploration Announces Start of Largest Grassroots Lithium Exploration Program in Eastern Canada
Nevada Sunrise Discovers 327.7 Mg/L Lithium in Water Analyses over 220 feet at the Gemini Lithium Project, Nevada
Landmark Five-Year Data from Phase 3 CheckMate -227 Trial Demonstrate Long-Term, Durable Survival Outcomes with Opdivo Plus Yervoy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer
Three-Year Data from Phase 3 CheckMate -9LA Trial Demonstrate Long-Term, Durable Survival Outcomes of Opdivo Plus Yervoy with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
"Captain Tsubasa: Dream Team" 5th Anniversary Kicks Off & New Players Wearing the JUVENTUS Official Kit Debut
Constantine Announces Palmer Project Manager/Senior Engineer for the Palmer Copper-Zinc-Silver-Gold Project, Southeast Alaska
Paradox Lithium Project Strategic Expansion: DFS Targeting Production Capacity of 10,000tpa of Battery-Grade Lithium Carbona
Late-Breaking Data Demonstrate Abbott's FreeStyle Libre® 3 System is Most Accurate 14-Day Continuous Glucose Monitor
Adjuvant Treatment With Merck's KEYTRUDA® Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Trial
NEW HEAD-TO-HEAD DATA SHOW VECTIBIX® DEMONSTRATED SUPERIOR OVERALL SURVIVAL COMPARED TO BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN JAPANESE PATIENTS WITH WILD-TYPE RAS COLORECTAL CANCER
Tecartus® Car T-cell Therapy Demonstrates Strong Overall Survival Rates and Continued Durable Responses in Long-Term Follow-Up of Two Pivotal Studies Including Longest Ever Follow-Up of a CAR T-cell Therapy in Mantle Cell Lymphoma
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors with Substantial Losses to Contact the Firm
Sub-analyses of Landmark ZUMA-7 Trial Reinforce Yescarta® CAR T-cell Therapy Superiority Over Standard of Care as Initial Treatment for Patients With Relapsed or Refractory Large B-cell Lymphoma
Everest Medicines' Licensing Partner Gilead Sciences Announces Positive Results from Phase 3 TROPiCS-02 Study of Trodelvy® in Heavily Pre-treated HR+/HER2- Metastatic Breast Cancer Patients
Pfizer Announces Overall Survival Results from Phase 3 PALOMA-2 Trial of IBRANCE® for the First-Line Treatment of ER+, HER2- Metastatic Breast Cancer
Trodelvy® Improved Progression-Free Survival by 34% in Heavily Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients
Royal Wins Announces Delay in Filing of Interim Financial Statements, MD&A and Related Certifications
Ur-Energy Reports Results of Annual General and Special Meeting of Shareholders and Appointment of Chairman of the Board
Bristol Myers Squibb Withdraws Supplemental Biologics License Application for Reblozyl® for Non-transfusion Dependent Beta Thalassemia
Yescarta® CAR T-cell Therapy Demonstrates Consistent Survival Outcomes and Safety in Real-World Setting Regardless of Race and Ethnicity
Karma the Game of Destiny and 1520 Records to Host a Live Music and Pre-Drop NFT Auction Event at Yonkers Brewery June 24, 4-8pm.
Aurinia Presents Data Demonstrating LUPKYNIS® is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
Rockstar Energy Drink Announces Multi-Year Partnership with Gaming and Entertainment Organization, NRG
Gamer rage is more than memes: Opera GX presents its first Rage Report with key insights on US and UK gamers' daily frustrations
Silver Hammer Announces Closing of Oversubscribed Private Placement for Gross Proceeds of Approximately $3,000,000
Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study